We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Continuous Regional Anesthesia for Septic Limb Orthopedic Surgery (ACOSM)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2013 by University Hospital, Strasbourg, France.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01947660
First Posted: September 20, 2013
Last Update Posted: September 20, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University Hospital, Strasbourg, France
  Purpose

This study aims to assess the safety of using continuous regional anesthesia for post-operative analgesia during septic limb orthopedic surgery.

The study hypothesis is that continuous regional anesthesia would not induce septic complication in the operated limb and could improve post-operative recovery.


Condition Intervention
Osteo Arthritis Cellulitis Drug: Systemic analgesia + Continuous regional anesthesia Drug: Systemic analgesia

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Continuous Regional Anesthesia for Septic Limb Orthopedic Surgery

Resource links provided by NLM:


Further study details as provided by University Hospital, Strasbourg, France:

Primary Outcome Measures:
  • Septic complication in the operated limb [ Time Frame: 28 days ]
    Septic complication in the operated limb Pain score Nausea and vomiting


Estimated Enrollment: 260
Study Start Date: October 2013
Estimated Study Completion Date: November 2015
Estimated Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Continuous regional anesthesia Drug: Systemic analgesia + Continuous regional anesthesia
Systemic analgesia + Continuous regional anesthesia, peri neural for the 2 to 4 first days post-operative
Active Comparator: Systemic analgesia Drug: Systemic analgesia
Systemic analgesia as usual

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Osteo arthritis or cellulitis requiring surgical intervention
  • anatomical possibility of regional anesthesia
  • age >18 ans
  • written informed consent

Exclusion Criteria:

  • loco-regional anesthesia impossibility (puncture zone infection, local anesthesics allergie, amiodarone or mexilétine treatment, neurologic deficit for exemple)
  • patient under tutelle or curatelle
  • pregnant or beast feeding woman
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01947660


Contacts
Contact: Pierre DIEMUNSCH, PU PH 03 88 12 70 76 pierre.diemunsch@chru-strasbourg.fr
Contact: Eric NOLL, PH 03 88 55 23 37 eric.noll@chru-strasbourg.fr

Locations
France
CCOM Not yet recruiting
Illkirch, Alsace, France, 67400
Contact: Eric NOLL, PH    03 88 55 23 37      
Sub-Investigator: KEMPF, PU PH         
Sub-Investigator: NOLL, PH         
Sub-Investigator: GAUDIAS, PH         
Sub-Investigator: JENNY, PH         
Sub-Investigator: CLAVERT, PU PH         
Sub-Investigator: LAALOU, PH         
Sub-Investigator: BOERI, PH         
Sponsors and Collaborators
University Hospital, Strasbourg, France
  More Information

Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT01947660     History of Changes
Other Study ID Numbers: 5492
First Submitted: September 17, 2013
First Posted: September 20, 2013
Last Update Posted: September 20, 2013
Last Verified: September 2013

Additional relevant MeSH terms:
Cellulitis
Osteoarthritis
Skin Diseases, Infectious
Infection
Suppuration
Connective Tissue Diseases
Inflammation
Pathologic Processes
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs